Samir Adhikari

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trial”.

A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trial

Nature Medicine(2025)10.1038/s41591-025-03995-y

N/A

0.302DataRank · unranked

6 citations

Allison M. Kirk, Brian H. Ladle, Zeal Kamdar, Kayla J. Bendinelli, Won Jin Ho +23 more

TIRTL-seq: deep, quantitative and affordable paired TCR repertoire sequencing

Nature Methods(2025)10.1038/s41592-025-02907-9

N/A

0DataRank · unranked

11 citations

Allison M. Kirk, Samir Adhikari, Anastasia A. Minervina, Balaji Sundararaman, Kasi Vegesana +30 more

TIRTL-seq 384-well v1

(2025)10.17504/protocols.io.eq2lyx37wgx9/v1

N/A

0DataRank · unranked

0 citations

Allison M. Kirk, Samir Adhikari, Balaji Sundararaman, Paul G. Thomas, Mikhail V. Pogorelyy

TIRTL-seq 96-well v1

(2025)10.17504/protocols.io.kqdg3k6xpv25/v1

N/A

0DataRank · unranked

0 citations

Allison M. Kirk, Samir Adhikari, Balaji Sundararaman, Paul G. Thomas, Mikhail V. Pogorelyy

TIRTL-seq 96-well v2

(2025)10.17504/protocols.io.kqdg3k6xpv25/v2

N/A

0DataRank · unranked

0 citations

Allison M. Kirk, Samir Adhikari, Balaji Sundararaman, Paul Thomas, Mikhail V. Pogorelyy

TIRTL-seq 384-well v2

(2025)10.17504/protocols.io.eq2lyx37wgx9/v2

N/A

0DataRank · unranked

0 citations

Allison M. Kirk, Samir Adhikari, Balaji Sundararaman, Paul G. Thomas, Mikhail V. Pogorelyy